Tag Archive for Stemtech

Hot Business News Today

Stemtech Welcomes Dr. Zahooruddin to Its Life Sciences Advisory Board

by  •  • 0 Comments

Naples, Florida – Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Zahooruddin, MBBS (MD), DAASCP to the Stemtech Life Sciences Advisory Board.
President & COO, John W. Meyer stated:

“We are pleased to have Dr. Zahooruddin join the Stemtech Life Sciences Advisory Board, along with Stemtech Corporation Chief Scientific Officer, Dr. Lizette Leos, MD, and Dr. Enrique Martinez, MD. Their combined knowledge and expertise creates a tremendous scientific / medical collaboration to improve the quality of life for many people through utilizing Stemtech’s stemceutical™ products. Together they will expand our science with new and innovative products. Dr. Zahooruddin has been using Stemtech products since 2010 for his patients in his practice in Pakistan.”

Dr. Zahooruddin is a board-certified stem cell physician, internationally trained stem cell and regenerative medicine physician and wellness expert with over 20 years of clinical and regenerative medicine experience. He is a diplomate of the American Academy of Stem Cell Physicians (AASCP, USA) and fellow of leading international stem cell and cell therapy associations in the USA and Europe. Dr. Zahooruddin’s expertise spans stem cell therapies, functional nutrition, metabolic optimization, and lifestyle medicine, focusing on reversal of diabetes, hypertension, cardiovascular disease, and metabolic disorders. He also specializes in

Read more...

Hot Business News Today

Stemtech Launches StemPets(TM), All-Natural Longevity Nutraceuticals Developed for Pets

by  •  • 0 Comments

Stemtech Corporation (OTCQB:STEK), the global leader in Human stem cell nutrition science and nutraceutical innovation, proudly announces the launch of StemPets™, Our newest breakthrough product designed exclusively for pets. Commencing June 2025, pet owners in the United States will be able to order this revolutionary new supplement, with availability in Mexico launching shortly after.

Made with 100% plant-based, natural ingredients, StemPets™ is a first-of-its-kind anti-aging and longevity formula for dogs and cats.

“This great new product will provide anti-aging and longevity for our four-legged furry family members*,”

said John W. Meyer, President and COO of Stemtech.

“Just add it onto their regular food as directed, and you’ll begin to notice benefits like increased energy levels, a shinier coat, healthier skin, better digestion, and improved joint health”.

Built on nearly two decades of innovation and success with human products like StemRelease3™, StemFlo® Advanced, and MigraStem®, StemPets™ represents the company’s natural expansion into the booming pet wellness market.
A Multi-Billion Dollar Opportunity
The overall pet care industry is projected to surpass $500 billion globally by 2030, driven by increasing pet personal care and animal health awareness (source: Morgan Stanley, 2023).

“StemPets™ taps into currently one of the most explosive growth sectors in health and wellness,”

added Meyer.

“As more consumers

Read more...

Hot Business News Today

Stemtech Announces Leadership Additions and StemPets™ Launch in Q2 2025

by  •  • 0 Comments

Stemtech (OTCQB:STEK), a global leader in stem cell nutrition, is proud to announce strategic leadership appointments and the upcoming launch of its highly anticipated StemPets™ product line. Committed to enhancing health for individuals and pets alike, Stemtech continues to drive innovation in the wellness space.
StemPets™: A Game Changer in Pet Health
Stemtech is set to launch StemPets in early Q2 of 2025, marking its entry into the booming pet healthcare sector, projected to exceed $303 billion by 2027.
John W. Meyer, President & COO of Stemtech said:

“We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners. StemPets is a game changer in pet care, uniquely positioning us to capture market growth with science-backed products.”

Strategic Leadership Appointments
To drive global expansion, Stemtech welcomes key executives:

Alejandro Carrillo, Vice President of Global Operations, will oversee manufacturing, inventory, and expansion management.
Srilakshmi Vadlapatla, Global Accounts Manager and future CFO, will lead financial strategy, bringing vast experience in international finance.
Manuel Ramirez Garcia, Director of Global Sales & Field Development, will spearhead global sales strategy and market expansion, leveraging over 20 years of experience.

“We are thrilled to have Srilakshmi and Manuel join our leadership team and Alex in his new

Read more...

Hot Business News Today

Stemtech, Viago And Eevia Health Announce Proposed RTO

by  •  • 0 Comments

Stemtech Corporation (OTCQB:STEK), a US-based company announced this past Tuesday its planned merger (“Merger”) with Seacret Direct, LLC (“VIÁGO”) and now announces a proposal for a Reverse Takeover (RTO) of Eevia Health Plc (“Eevia”), a Finnish producer of bioactive organic Arctic plant extracts and nutraceuticals and has its common stock listed on the Swedish Spotlight Stock Market under the symbol “EEVIA”.
This strategic RTO marks a major milestone in the evolution of the combined companies, intending to create a vertically integrated health, wellness, and lifestyle entity that manufactures its own products and is positioned for significant growth in the global marketplace.
Reverse Takeover Structure and Valuation:
Under the proposed RTO, Eevia will acquire the assets and assume the liabilities of Stemtech and, upon completion of the Merger, VIÁGO by Eevia issuing new shares, resulting in Stemtech owning approximately 85% of Eevia, with the remaining 15% of the Eevia shares owned by its existing shareholders. The final valuation, share issuance, and terms are subject to conditions, including the negotiation of the definitive agreements, a third -party valuation, and the completion of the due diligence process.
Synergies and Strategic Rationale: 
Stemtech and VIÁGO have identified Eevia’s advanced production facility in Kauhajoki, Finland, as a planned significant resource

Read more...

Hot Business News Today

Seacret Direct (VIAGO) and Stemtech Merge

by  •  • 0 Comments

Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO) are pleased to announce they have reached an agreement in principle to merge their businesses. This merger represents a transformative step forward for both organizations, aiming to drive significant growth and enhance shareholder value.
Charles S. Arnold, CEO and Chairman of Stemtech, stated,

“This union positions us for accelerated growth and brings substantial value to our shareholders. Together, we are building a stronger future for our combined companies and their subsidiaries.”

Upon finalization of the merger,

Charles S. Arnold will continue as Chairman of the holding company,
VIÁGO’s Izhak Ben Shabat will assume the role of Chief Executive Officer.
The executive leadership team will be further led by Eddie Head (from VIÁGO) as President and Chief Strategy Officer and
John W. Meyer (from Stemtech) as President and Chief Operating Officer.

Arnold further commented,

“The merger creates an exciting future for VIÁGO and Stemtech, uniting our strengths and offering greater opportunities for our members, customers, and affiliates. This is a partnership rooted in mutual growth and shared vision.”

VIÁGO CEO Izhak Ben Shabat added,

“This unites two well-established companies in a public forum, maximizing value for stakeholders-customers, affiliates, and shareholders alike. It also empowers the community to share in the company’s

Read more...

Hot Business News Today

Stemtech Announces The Launch of StemPets

by  •  • 0 Comments

Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of stemceutical™ products for humans offered since 2005, is proud to announce an exciting new product line into the pet health care industry with the launch of “StemPets™.”
This revolutionary product is designed to provide substantial health benefits to dogs, cats, and other beloved pets, tapping into the $303 billion pet health care market.
Recognizing the profound love humans hold for their pets and the significant expenses they incur to keep them healthy, Stemtech has developed StemPets. This natural stemceutical product promises to offer amazing health benefits to pets as our human products have provided for nearly two decades.

“We are thrilled to introduce StemPets to the market,” said Charles S. Arnold”, Chairman & CEO of Stemtech.

He goes on to say that

“pet owners go to great lengths to ensure the well-being of their animals, and StemPets offers a natural solution that supports their health. Our product is not only beneficial for pet health, but is also appealing to them, as animals find the natural flavor pleasant without the need for artificial flavoring. My eight-year-old dog Plato has more energy and vitality since taking StemPets.”

John W. Meyer, President & COO states

“the new StemPets

Read more...

Hot Business News Today

Stemtech Expands Global Reach With New License Agreement In Africa

by  •  • 0 Comments

Stemtech Corporation (OTCQB:STEK), a leading innovator in patented stem cell nutrition health products, announces a significant milestone in its global expansion strategy with the signing of a license Agreement with an established direct sales company, based in Kenya.
The Agreement, effective January 29th, 2024, grants the license to purchase, use, market, and distribute Stemtech’s cutting-edge health related products within the designated Territory(s), including Kenya, Uganda, Tanzania, Ghana, Democratic Republic of Congo and Nigeria.
This strategic move represents Stemtech’s commitment to reaching new markets and introducing its patented stem cell nutrition, skin care and oral care products to new markets. The licensing agreement includes the distribution of StemRelease3™, StemFlo Advanced®, MigraStem™, OraStem™, and Cellect One™ Rapid Renew Stem Cell Peptide Night Cream.
John W. Meyer, President & COO of Stemtech Corporation, expressed excitement about the expansion, stating,

“We believe that this partnership marks a significant opportunity for Stemtech to establish brand recognition in key African markets and contribute to the overall health and wellness of the region.
We are confident that our stem cell nutrition products will make a positive impact and contribute to the growth of the wellness industry in Africa. Distributors will benefit from additional income for the current network marketers already engaged through

Read more...

Hot Business News Today

Stemtech Announces Jeff Weisberg As Director Of New Business Development

by  •  • 0 Comments

Stemtech President and COO, John W. Meyer, comments that “the addition of Jeff Weisberg, with his vast experience in direct sales, having generated approximately a billion dollars in sales over his decades long career, joins us to further expand our growing Field of Stemtech distributors and consumers.
His global experience in this $200 billion-dollar direct sales industry entails coaching, training, motivation and working with some of the most successful companies over the span of his career.
This fits into our Vision 2023 expansion strategy perfectly. Jeff, a serial entrepreneur who has also run his own businesses, in addition to developing others as a consultant, has experience in bringing innovative products to the marketplace that are not sold through traditional retail stores, but that develop distribution through the network marketing model.
His years of experience are not only in the U.S., but globally including Asia, Europe, the Middle East and Latin America. Jeff will complement Stemtech’s existing operations and energize our current Stemtech business partners while adding new leaders as well as new consumers.
Jeff has accomplished and achieved great success and we look forward to working with him”. Meyer goes on to say that “Jeff Weisberg’s first responsibility will be conducting training

Read more...

Hot Business News Today

StemTech Launches In Colombia

by  •  • 0 Comments

President and Chief Operating Officer, John W. Meyer, says:
“Stemtech has started working to launch Stemtech Colombia with our country offices intended to be located in Bogota. During our Leadership Event held last December 2022 in Cancun, Mexico, we were requested by our Field leaders to undertake opening a Colombia office.
Given the existing relationships between our Latin American Independent Business Partners (IBPs) and residents in that country. This also fits into our company concept of ‘Just One More’ by adding a new market”.
Stemtech CEO, Charles S. Arnold, says:
“Colombia is a very exciting market for Stemtech as it is a great country in which to introduce the health and wellness benefits of our anti-aging, all-natural, plant-based stemceutical™ products.
In addition, technology advances we have made with our AdvanceOffice mobile app, will help to provide leading-edge communication and easier recruiting tools for our IBPs to share the Stemtech opportunity for building an entrepreneurial business for Colombian citizens with the opportunity to earn additional income”.
Stemtech`s Vice President of Global Sales, Alejandro Carrillo states:
“the VISION 2023 strategic business plan initiative includes expansion of our Latin American markets. This is the first step toward achieving this objective this year. Colombia is an opportunity as one

Read more...

Hot Business News Today

Stemtech Anticipates Growth Rate In 2023 Will Exceed 2022

by  •  • 0 Comments

Stemtech today announced VISION 2023 concerning the exciting developments planned for the new year.
President and Chief Operating Officer, John W. Meyer says that “VISION 2023 for Stemtech was built on the foundations we enacted over the course of 2022.
“Our efforts were rewarded with a 20% growth of new Independent Business Partners (IBPs) and customers over FY 2021. We anticipate that this growth rate will actually be exceeded this year.
We introduced the powerful AdvanceOffice Mobile app for all of our distributors which enables them to operate their entire business via the app.
We launched a new proprietary blend named “CellectOne™”, a Rapid Renew Stem Cell Peptide Night Cream; we held our international conference in Cancun, Mexico this past December. Each one of these investments have generated exciting growth far beyond our expectations”
“For the upcoming fiscal year, we expect to increase our customer base as well as revenue. Much of this stems not only from our new product lines or increasing sales, but as much our human factor.
Our Field attendees came away from our Cancun event filled with excitement and new strategies to take to their customers, sharing the many opportunities of Stemtech.
We believe that sales will increase considerably in 2023

Read more...